Bicycle Therapeutics plc Deferred Tax Assets, Operating Loss Carryforwards, Foreign
Bicycle Therapeutics plc (BCYC) had Deferred Tax Assets, Operating Loss Carryforwards, Foreign of $405.30 million as of 2025-12-31, per its 10-K filed 2026-03-17.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign · last filed 2026-03-17
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $405.30M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $326.00M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $266.20M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $181.80M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Foreign |
|---|---|
| 2025-12-31 | $405.30M 10-K · filed 2026-03-17 |
| 2024-12-31 | $326.00M 10-K · filed 2025-02-25 |
| 2023-12-31 | $266.20M 10-K · filed 2024-02-20 |
| 2022-12-31 | $181.80M 10-K · filed 2023-02-28 |
| 2021-12-31 | $120.30M 10-K · filed 2022-03-01 |
| 2020-12-31 | $72.00M 10-K · filed 2021-03-11 |
| 2019-12-31 | $41.70M 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |